View the February 2012 Contents
Inverse parabola biotechs aren’t anything new with 2011. “Failure” is an interesting word in the medtech industry. One doesn’t just need to disappear to fail miserably compared to the recent past. — Paul Stein, The Companies that Failed
Inverse parabola biotechs aren’t anything new with 2011. “Failure” is an interesting word in the medtech industry. One doesn’t just need to disappear to fail miserably compared to the recent past.
Subscribe to the Magazine
Register for FREE Online Access
